NCT06411015View on ClinicalTrials.gov

Prognostic Evaluation Prediction Model Survival Spinal Epidural Metastases

CompletedOBSERVATIONAL
Enrollment

428

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

May 1, 2024

Conditions
Predictive Cancer Model
Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT06411015 - Prognostic Evaluation Prediction Model Survival Spinal Epidural Metastases | Biotech Hunter | Biotech Hunter